BluDerma
SM Lido Cream

Austin Pharm Co., Ltd.

SM Lido Cream

Brand

Austin Pharm Co., Ltd.

Category

Topical Anaesthetic

Origin

Korea

Options

500 g · 30 g

Available options

500 g30 g

Interested in ordering SM Lido Cream? Send an enquiry and our team will follow up with availability and pricing.

Overview

SM Lido Cream is a Korean professional-grade topical anaesthetic containing 10.56% lidocaine, used to numb intact skin ahead of injectable, laser and needling procedures. It is a single-agent amide-anaesthetic cream intended for cutaneous use during aesthetic corrections in clinics and treatment rooms. Supplied in 30 g tubes and 500 g bulk jars for clinical dispensing.

How it works

Lidocaine penetrates the epidermis and reversibly blocks voltage-gated sodium channels in cutaneous nerve endings, preventing the depolarisation that transmits pain. Applied thickly under occlusion, the cream hydrates the stratum corneum and enhances drug uptake into the superficial skin layers so the target area is desensitised before the procedure.

Indications

  • Pre-injection anaesthesia for fillers and neuromodulators
  • Mesotherapy and skin-booster injections
  • Microneedling procedures
  • Laser hair removal and laser resurfacing
  • Tattoo and permanent make-up work

Key features

  • 10.56% lidocaine single-agent formulation
  • KFDA-compliant Korean manufacture
  • Designed for deep, fast-onset cutaneous numbing
  • Clinic (30 g) and bulk (500 g) pack options
  • Cream base suited to occlusive application

Benefits

  • Enhances patient tolerance of needle- and energy-based treatments
  • Bulk sizing supports cost-effective high-throughput practice
  • Reliable onset aids consistent appointment timing
  • Established Korean anaesthetic brand for straightforward resupply
  • Simple single-active profile eases practitioner and patient communication

Composition

Lidocaine 10.56% (105.6 mg/g) as the single active anaesthetic in a cream base.

Usage & handling

Apply a generous, even layer to clean intact skin and occlude for the manufacturer-stated contact time before treatment. Respect the maximum recommended surface area and contact time to minimise systemic absorption, and lower the dose on thin or broken-barrier skin. Remove residue thoroughly before energy-based (laser/RF) procedures. Do not use on damaged, inflamed or infected skin; intended for professional use.

For medical professionals. Product information is for reference and does not replace the manufacturer's instructions for use. Availability and regulatory status vary by region.